Siqing Wang

发表

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.

F. Zhan, B. Barlogie, J. Shaughnessy, 2010, Blood.

Application Of Adoptive Immunotherapy In Ovarian Cancer

Siqing Wang, Siyu Yang, Xiaojiao Yin, 2019, OncoTargets and therapy.

Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells

Siqing Wang, Xingzhe Ma, Yong Lu, 2016, Nature Communications.

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Michael L. Wang, L. Kwak, Liang Zhang, 2009, Blood.

Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.

Michael L. Wang, B. Barlogie, L. Kwak, 2006, Cancer cell.

Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

Michael L. Wang, X. Zhang, Sungyoul Hong, 2009, Blood.

Tumor-specific IL-9–producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers

Yuhuan Zheng, Siqing Wang, Bangxing Hong, 2014, Proceedings of the National Academy of Sciences.

p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression

J. Hou, Yuhuan Zheng, Siqing Wang, 2014, Nature Communications.

TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways

Siqing Wang, E. Bi, Yinghua Zhao, 2019, Journal of Immunotherapy for Cancer.

TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation

Hong Zhang, Siqing Wang, Sujun Gao, 2020, Journal of immunotherapy.

Dectin-1 stimulates IL-33 expression in dendritic cells via upregulation of IRF4

Siqing Wang, Xiaohuan Wang, Ying Yue, 2018, Laboratory Investigation.

Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters.

Zhe-Sheng Chen, A. Tiwari, C. Ashby, 2009, Biochemical pharmacology.

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 (Cancer Research (2008) 68, (7905-7914))

Liwu Fu, R. Robey, S. Ambudkar, 2008 .

Mitogen-Activated Protein Kinase p38 Immature Dendritic Cells: Involvement of of Lipopolysaccharide on In Vitro Generation Novel and Detrimental Effects of

J. Epstein, Siqing Wang, J. Qian, 2003 .

Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells

R. Gu, Siqing Wang, H. Yi, 2018, Front. Immunol..

IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells

Siqing Wang, Ying Yue, Yinghua Zhao, 2018, Cellular & Molecular Immunology.

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7

Maojie Yang, Siqing Wang, E. Bi, 2017, Science Signaling.

Running title: Role of RAR 2 in multiple myeloma

F. Zhan, B. Barlogie, J. Shaughnessy, 2013 .

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.

F. Zhan, B. Barlogie, J. Shaughnessy, 2009, Blood.

RAR (cid:1) 2 expression is associated with disease progression and plays a crucial role in efﬁcacy of ATRA treatment in myeloma

F. Zhan, B. Barlogie, J. Shaughnessy, 2009 .

Spatiotemporal pattern of TRAF3 expression after rat spinal cord injury

Lei Xu, Siqing Wang, Xiaozu Xu, 2014, Journal of Molecular Histology.

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

R. Robey, S. Ambudkar, Zhe-Sheng Chen, 2008, Cancer research.

Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells.

E. Shpall, L. Kwak, Sungyoul Hong, 2006, Blood.

Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma.

L. Kwak, Siqing Wang, Jing Yang, 2006, Blood.

Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL

D. Hermann, Yun Dai, Siqing Wang, 2017, Oncotarget.

Targeting Heat Shock Proteins for Immunotherapy in Multiple Myeloma: Generation of Myeloma-Specific CTLs Using Dendritic Cells Pulsed with Tumor-Derived gp96

Jin Xie, P. Lin, Siqing Wang, 2005, Clinical Cancer Research.

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.

F. Zhan, B. Barlogie, J. Shaughnessy, 2008, Blood.

Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance

F. Zhan, Gui-yuan Li, G. Tricot, 2010, Oncotarget.

Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1.

Siqing Wang, Xiaoqin Zhu, Yinghua Zhao, 2017, Oncotarget.

Novel and Detrimental Effects of Lipopolysaccharide on In Vitro Generation of Immature Dendritic Cells: Involvement of Mitogen-Activated Protein Kinase p38 1

J. Epstein, Jin Xie, Siqing Wang, 2003, The Journal of Immunology.

Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma

Hua Zhang, Siqing Wang, Jintong Chen, 2022, Medical Oncology.

Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells.

Jin Xie, Siqing Wang, Jing Yang, 2005, Experimental hematology.

Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.

Sungyoul Hong, Siqing Wang, Jing Yang, 2007, Frontiers in bioscience : a journal and virtual library.

Targeting β 2 -Microglobulin for Induction of Tumor Apoptosis in Human Hematological Malignancies.

L. Kwak, Siqing Wang, Jing Yang, 2005 .

Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1

Siqing Wang, Xiaoqin Zhu, Yinghua Zhao, 2017, Oncotarget.

IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells

Siqing Wang, Ying Yue, Yinghua Zhao, 2018, Cellular & Molecular Immunology.

Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Siqing Wang, Ying Yue, Yinghua Zhao, 2021, Oncology letters.

Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma

J. Hou, Q. Wang, Yuhuan Zheng, 2018, Leukemia.

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7

Maojie Yang, Siqing Wang, J. Qian, 2017, Science Signaling.

This information is current as Mitogen-Activated Protein Kinase p 38 Immature Dendritic Cells : Involvement of ofLipopolysaccharide on In Vitro Generation Novel and Detrimental Effects of

J. Epstein, Siqing Wang, J. Qian, 2003 .

Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy

Siqing Wang, Yong Lu, Yinghua Zhao, 2016, Oncoimmunology.